ClinicalTrials.gg
RecruitingNCT07844395Updated Sep 28, 2026

The Effect of Using a Stress Ball on Pain, Anxiety, and Vital Signs During Breast Biopsy

An interventional study of Using a Stress Ball in Breast Biopsy, Procedural Pain and Anxiety, sponsored by TC Erciyes University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by TC Erciyes University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Sep 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Pain, Procedural with a site in Turkey — 14 open to participants now, 14 under way, none of them phase 3. Pain, Procedural · Turkey.

Planned enrollment
74th of 79
53 · median 100
Started
2026
with 19 others
No phase
77 of 81
13 open now
Primary completion
2026-10
later than 5 of 13 live
Registered
70th of 81
by date

Among the 81 studies in Pain, Procedural with a site in Turkey, this one is the 74th largest by planned enrollment of the 79 interventional ones that give a count, is one of 20 that started in 2026, is one of 77 with no phase, reaches primary completion later than 5 of the 13 other live ones, and was the 70th registered.

Pain, Procedural

246 studies on the registry are indexed under Pain, Procedural; 66 are open to participants now.

Browse Pain, Procedural studies →

Open to participants now

14 of the 81 studies in Pain, Procedural with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 30 Pain, Procedural studies recruiting now, 13 (43%) set no upper age limit and 15 (50%) stop at 75 or younger; 14 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Pain, Procedural with a site in Turkey, or all of them as a file.
02

Study summary

Breast biopsy is an invasive diagnostic procedure commonly performed for the histopathological diagnosis of breast lesions and can be associated with anxiety and pain. Procedural anxiety and pain may also influence physiological responses, including changes in blood pressure and heart rate. Therefore, non-pharmacological nursing interventions that are simple, low-cost, and easy to implement may be useful in managing procedural distress.

This study aims to investigate the effect of stress ball use during breast biopsy on patients' pain, anxiety, and vital signs. Participants will be assigned to an intervention group using a stress ball during the biopsy procedure or a control group receiving standard care. Pain and anxiety levels, as well as vital signs, will be assessed and compared between the two groups.

03

Conditions studied

  • Breast Biopsy
  • Procedural Pain
  • Anxiety
  • Vital Signs

Keywords

  • stress ball
  • distraction
  • nursing intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for Tru-Cut breast
  • Aged 18 years and older
  • Undergoing breast biopsy for the first time
  • Able to speak Turkish
  • Female sex
  • Not pregnant
  • Not breastfeeding
  • No cognitive, verbal, or hearing impairments that could impede communication
  • Voluntarily agreeing to participate in the study with written and verbal

Exclusion criteria

Exclusion Criteria:

  • Chronic pain disorders or regular use of analgesics
  • Having taken analgesic medication on the day of the procedure
  • Inability to use the hands or impaired grip/grasp function
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
53 participants (estimated)

Study arms

  • Experimental
    Stress Ball

    Participants in this group will squeeze a stress ball during the breast biopsy procedure.

    Behavioral: Using a Stress Ball

  • No intervention
    Routine Care

    Participants will receive standard care without any stress ball application.

Interventions

  • BehavioralUsing a Stress Ball

    Participants will squeeze a stress ball during the biopsy procedure

06

What researchers measure

Primary outcomes

  1. Pain Score Assessed by Visual Analog Scale (VAS)

    Pain intensity will be evaluated using a 10-cm Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain imaginable). Higher scores indicate greater pain intensity.

    Time frame: Immediately after the biopsy procedure

Secondary outcomes

  1. Anxiety Score Assessed by State-Trait Anxiety Inventory (STAI-S)

    Situational anxiety will be assessed using the State Anxiety Scale (STAI-S). Scores range from 20 to 80, with higher scores reflecting higher anxiety levels.

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

  2. Trait Anxiety Score Assessed by State-Trait Anxiety Inventory (STAI-T)

    General anxiety disposition will be assessed using the Trait Anxiety Scale (STAI Form TX-2 / STAI-T). The total score ranges from 20 to 80, with higher scores reflecting higher levels of trait anxiety.

    Time frame: Immediately after the biopsy procedure

  3. Changes in Vital Signs (Body Temperature)

    Body temperature (°C) will be recorded.

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

  4. Changes in Vital Signs (Heart Rate)

    Heart rate will be recorded in beats per minute (bpm).

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

  5. Changes in Vital Signs (Respiratory Rate)

    Respiratory rate will be recorded in breaths per minute.

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

  6. Changes in Vital Signs (Systolic Blood Pressure)

    Systolic blood pressure (mmHg) will be recorded.

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

  7. Changes in Vital Signs (Diastolic Blood Pressure)

    Diastolic blood pressure (mmHg) will be recorded.

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

  8. Changes in Vital Signs (Peripheral Oxygen Saturation)

    Peripheral oxygen saturation (SpO2, %) will be recorded.

    Time frame: Baseline (before the procedure) and immediately after the biopsy procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Oct 2026, 1 month after the start.

Of 145 non-industry interventional studies with no phase under Pain, Procedural, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 1 month is below that.

Counting every sponsor, half of 145 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2026
First posted
Sep 28, 2026
StartActual
Sep 11, 2026
Primary completionEst.
Oct 11, 2026
CompletionEst.
Oct 31, 2026
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07844395
Responsible party
Meryem Tugba Ton (Nurse, TC Erciyes University) — Principal investigator
First posted
Sep 28, 2026
Start date
Sep 11, 2026
Primary completion
Oct 11, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Sep 28, 2026

Study contacts

Evrim Bayraktar, Assoc. Prof. Dr.
Contact
ealbayrak@erciyes.edu.tr
+905332156825
Meryem Tuğba Ton, RN, BSN
Contact
meryemtubaton@gmail.com
+905078781249
Evrim Bayraktar, Assoc. Prof. Dr.
study director · TC Erciyes University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion